- Home
- BAP vs BNTX Comparison
BAP vs BNTX Comparison
Compare BAP & BNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BAP | BNTX |
|---|---|---|
| Founded | 1889 | 2008 |
| Country | Peru | Germany |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 21.1B | 24.8B |
| IPO Year | 1995 | 2019 |
Fundamental Metrics
Financial Performance| Metric | BAP | BNTX |
|---|---|---|
| Price | $320.75 | $108.22 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 5 | 11 |
| Target Price | ★ $284.20 | $140.31 |
| AVG Volume (30 Days) | 315.7K | ★ 1.1M |
| Earning Date | 02-12-2026 | 11-03-2025 |
| Dividend Yield | ★ 3.42% | N/A |
| EPS Growth | ★ 24.08 | N/A |
| EPS | ★ 23.44 | N/A |
| Revenue | ★ $5,896,627,147.00 | $3,698,814,972.00 |
| Revenue This Year | $23.30 | $2.03 |
| Revenue Next Year | $8.99 | N/A |
| P/E Ratio | $13.73 | ★ N/A |
| Revenue Growth | ★ 19.24 | 3.70 |
| 52 Week Low | $165.51 | $81.20 |
| 52 Week High | $322.77 | $126.77 |
Technical Indicators
Market Signals| Indicator | BAP | BNTX |
|---|---|---|
| Relative Strength Index (RSI) | 81.05 | 70.02 |
| Support Level | $291.00 | $105.16 |
| Resistance Level | $322.77 | $109.28 |
| Average True Range (ATR) | 5.87 | 2.35 |
| MACD | 1.99 | 1.52 |
| Stochastic Oscillator | 95.02 | 83.23 |
Price Performance
Historical ComparisonAbout BAP Credicorp Ltd.
Credicorp Ltd is a Peruvian financial services company. It operates in four business lines, including Universal Banking, Insurance and Pensions, Microfinance, and Investment Management & Advisory. Its subsidiaries include Banco de Credito del Peru, Prima AFP, and Credicorp Capital. Geographically, the company operates in Peru, Colombia, Bolivia, Chile, Panama, the USA, and Mexico; the majority of its revenue is generated from Peru.
About BNTX BioNTech SE
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates, or ADCs. Comirnaty, its Pfizer-partnered covid vaccine, is its first commercialized product.